< B C957491E48E86312E696E6464>
|
|
|
- ゆりな かつもと
- 6 years ago
- Views:
Transcription
1
2
3
4
5
6
7 10 DDS New York Academy Renal Biochemistry (Elsevier) Glutathione (John Wiley & Sons) Antioxidants in Therapy and Preventive Medicine (Plenum) The Liver: Biology and Pathophysiology (Raven Press) NO SSC
8 Cu Zn Se A C E 2
9 1) 1) 1) 2) 3) 4) 1) 1) 1) 2) 3) 4) 1) ( ) ( ) CR ( ) RE RVA X C A 1) 32 p Cu CuCl2 P 8 Cu CuCl2 1.0 mg% min Cu 30 min 1/2 Cu CuCl2 Cu Cu
10 AIN93G 20 g/g Wistar , 2) 3) 2) 1) 2) 3) F344/N 3 17 AIN-93G AIN-93G 7 Student t A/G GOT 2 GPT ALP -GTP T3 T4 p = 0.069
11 3 ICR 1 kg 2 mg AIN-93G 1 AIN93G 10 HPLC Ca 1) 1) 1) 1) 1) 2) 2) 1) 1) 2) -3 FP FP FPH CHOL CHOL BA in vitro ] <> FP FPH 5 Wistar AIN93 50 FP FPH CHOL0.5% 0.1% 6 4 CHOL BA <In vitro > FP FPH CHOL BA FP FPH CHOL CHOL CHOL CHOL BA In vitro FP FPH BA CHOL FP BA CHOL FPH FP BA FP FPH CHOL CHOL BA BA FP FPH
12 Ca Mg Ca Mg AIN-93G AIN-93G Ca Mg 3 SD Ca Mg Ca 9K(CBD9K) mrna Ca TRPV6 mrna Mg TRPM6 mrna Ca Ca Mg Mg Ca CBD9K mrna TRPV6 mrna TRPV6 mrna CBD9K mrna Mg Mg TRPM6 mrna TRPM6 mrna Ca Mg 1, 5) 2, 5) 3) 4) 1) ( ) 2) 3) 4) ( ) 5) 4, 5) TBT TBT Ca 2+ TBT TBT Ca RCR-1 TBT 1 μm caspase-3 Propidium Iodide Ca 2+ TBT Ca 2+ Dulbecco s PBS (DPBS) BAPTA-AM 2. TBT Ca 2+ Ca 2+ Fura2-AM Ca 2+ calpain 3. JC-1 cytochrome c TBT RCR-1 caspase-3 Ca 2+ Ca 2+ calpain Ca 2+ BAPTA-AM Ca 2+ DPBS calpain cytochrome c TBT RCR-1 Ca 2+ 2
13 40 50 QOL PVEE PVEE HPLC Slc:ddY 9 OVX PVEE 20 mg/kg 8 Deoxyprydinoline DPD Tartarate Resistant Acid Phosphatase TRAP TRAP X CT TRAP mrna RT-PCR PVEE OVX TRAPmRNA DPD TRAP PVEE PVEE TRAP PVEE OVX PVEE 8 OVX PVEE PVEE 1) 2) 2) 2) 1) 2) ) Ca K Cu Mn Se medium chain fatty acids: MCT) Fe Zn Ca Cu BALB/C C mL G-50 G-100 G ICP-OES Fe Ca G-50 G-100 G-150
14 1) 1) 2) 1) 2) mM NADH 2. NADPH NADPH mm mm 2 mm 4. in vitro GSSG NADPH Ki 5 10 mm NAD(P)H
15 - 1) 1) 2) 1, 2) ArgRPseudomonas taetrolens NBRC 3460 D- 1) MALDI-TOF MS MALDI-TOF MS ArgR 2 A DTT B A B ArgR MALDI-TOF MS C47A/C73A-ArgR C47A/C73A-ArgR ArgR C47A/C73A-ArgR ArgR C47A/C73A-ArgR MALDI-TOF MS ArgR Cys47 Cys73 PLP ArgR ArgR 2 Cys Ala C47A/C73A-ArgR ArgR DTT Cys47-Cys73 ArgR ArgR Cys47-Cys73 ArgR 1) D. Matsui, T. Oikawa et al., (2009) Appl. Microbiol. Biotechnol., 83: ) 1) 2) 2) 1) 1) 2) K K1 K2 K3 4 K 4 SXR 4 K K1 K K K1 4 7 K K3 K K3 K K 58 mol/d K1 4 7 K3 (n = 4 5) Sep-Pak Silica HPLC K K1 4 7 K K1 7 K3 4 K K 4 K3
16 - FAD FMN 2-2-CAA CAA 16S rrna 2-CAA 2-CAA 2-CAA Pseudomonas sp. YL 2-CAA ,301 CAA67_YL CAA67_YL FAD 2-CAA H218O [18O] 2-CAA FAD FADH2 CAA67_YL NAD(P)H AXXGXXG NADH NADPH FAD NADH FAD CAA67_YL NADH FAD FADH2 2-1) 1) 1) 2) 2) 1) ( ) 2) 20 ppm 1 11 Wistar 220 g mg /kg Wistar 180 g AUC AUC
17 1) 2) 1) 2) (EPO) Biol Trace Elem Res 107: , 2005 HO-1 Sprague-Dawley 3 AIN-93G CONZn 4.5 mg/kg diet 4.5 ppm ZD Pair-Fed AIN-93G PF HO-1 Ret Fisher PLSD 5 HO-1 CON ZD 3 Ret HO-1 CON ZD PF EPO EPO PF Wistar AIN93G mg/kg mg /ml 3.19 mg/ml 800 ml/kg mg/kg 12.5 mg/kg 12.5 mg/kg
18 1, 4) 2) 3) 3) 4) 1) ( ) 2) 3) ( ) 4) TBT TBT 1. Wistar g TBT 2.5 mg/kg body weight CYH CYH 0.1 ppm 1 ppm 10 ppm 100 ppm TBT CYH 2. TBT TBT GC/MS 3. Hematoxylin-Eosin HE TdT-mediated dutp-biotin Nick End Labeling (TUNEL) TBT CHY ppm 50%GC/MS TBT TBT 24 TBT TUNEL TBT 1) 2) 1) 1) 2) Rb Rb Rb Rb Rb Rb Rb Rb Rb 4 Wistar 62 8 Rb ,000 ppm 46 Rb Williams 5% Rb Rb Rb 1 ppm Rb Rb 8 25 ppm ppm ppm Rb ppm Rb μg/g/ppm , Rb Rb ppm Rb Rb ppm Rb ppm
19 % * 1) 2) 1) 1) 3) 1) 2) 3) μg μg/ g 216 g 44.8% 41.4% 37.9% 27.6% ± 113 μg ± 103 μg ± 120 μg ± 102 μg 90% 400 μg 30%
20 1) 1) 2) 1) 2) μg/ 2 μg/ 5 μg/ ± 4.0 FFQ L. plantarum ATCC N 4.5 N 100 μl 100 μl nm ng/ml 2.9 ng/ml 2.8 ng/ml 2.3 ng/ml 18.8 μg/mgcre 24.3 μg/mgcre 13.2 μg/mgcre 14.6 μg/mgcre p < μg 34.8 μg 35.2 μg 36.0 ± 7.2 μg/2010 1, 2) 1, 2) 2) 2) 1) 2) 75 10% 1) 60% 40% 2) (1) (1) Katayama M, Sugawa-Katayama,Y (2007) Effect of temperature on the diminution of retained arsenic in dried Hijiki, Sargassum fusiforme (harvey) Setchell, by water-soaking., J. Home Econ. Jpn, 58, (2) Katayama M, Sugawa-Katayama Y, Yamaguchi Y, Murakami K, Hirata S (2008) Effect of temperature on the extraction of various arsenic compounds from dried Hijiki, Sargussum fusiforme by water-soaking as a pre-cooking process. Trace Nutrients Research 25:
21 Se- GC-MS Se- - -Se- LC-MS g/g g 0.1 ml 0.45 m LC-MS Applied Biosystems, API 3000 Cadenza CD-C18 Imtact/70/ / ml/min Inertsil ODS-3 GL Sciences /80/ / ml/min - -Se- LC-MS LC Se- - -Se- Se- - -Se- LC-MS 1) 2) 3) 4) 1) 1) 1) 2) 3) 4) NaKCa Mg P S ZnFe Cu Ca Na Zn Fe 40
22 1) 1) 2) 2) 3) 3) 1) 1, 2) 1) 1) 2) 3) 1, 2) Klotho Klotho KO Klotho Klotho 500 g 550 g SD F 40 calorie restriction CR Klotho real-time PCR Klotho SDS-PAGE F ± 13.7 g ± 15.5 g F 60 CR ± 17.2 g ± 9.8 g Real-time PCR Klotho m-rna F CR 1.5 SDS-PAGE Klotho F CR Klotho
Microsoft Word - 14_LCMS_アクリルアミド
3--2-3-Iodo-2-propynyl butylcarbamate (IPBC) Carbamic acid, butyl-, 3-iodo-2-propynyl ester Iodocarb CAS 55406-53-6 C 8 H 12 NO 2 I C (g/cm 3 ) (mmhg) log P ow 281.09 (280.9910) 64 68 1.51 1.57 (20 C)
☆H23 13-農薬一斉分析(大垣).doc
13 56 2011 Examination of Determination of Residual Pesticides in Agricultural Products Yuki OHGAKI, Katsuhiro HAYASHI, Hiroyuki KAWAI, and Kyoko SHIMURA GC/MS 92 LC/MS/MS 60 150 n- 5 GC/MS 92 79 70% LC/MS/MS
JAJP
Agilent 7500ce ORS ICP-MS Glenn Woods Agilent Technologies Ltd. 5500 Lakeside, Cheadle Royal Business Park Stockport UK Agilent 7500ce ICP-MS 5 7500ce (ORS) 1 ORS 7500ce ORS ICP-MS ( ) 7500 ICP-MS (27.12
ッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)
Agilent AA ICP ICP-MS ICP-MS AA 55B AA LCD AA PC PC 240 AA / / AA 240FS/280FS AA AA FS 240Z/280Z AA GFAA AA Duo 1 PC AA 2 280FS AA
Agilent Agilent AA 195750 ICP ICP-MS ICP-MS AA 55B AA LCD AA PC PC 240 AA / / AA 240FS/280FS AA AA FS 240Z/280Z AA GFAA AA Duo 1 PC AA 2 280FS AA 1938 HP 1965 HP 1976 GC/MS HP 5992A 1983 GC GC HP 5890A
Agilent 7900 ICP-MS 1 1 Ed McCurdy 2 1 Agilent Technologies, Japan 2 Agilent Technologies, UK
Agilent 7900 ICP-MS 1 1 Ed McCurdy 2 1 Agilent Technologies, Japan 2 Agilent Technologies, UK Na P K Ca Co Cu Sr Cd Ce Cs Tl 11 [1]18 [2] (FAO) (WTO) (Codex) Pb Cd As Sn Pb 0.3 mg/kg Cd 0.4 mg/kg 0.2 mg/kg
2 1 7 - TALK ABOUT 21 μ TALK ABOUT 21 Ag As Se 2. 2. 2. Ag As Se 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 Sb Ga Te 2. Sb 2. Ga 2. Te 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4
untitled
ORYZA CERAMIDE -PTPCDP8TP20CD -WSPWSP8 -LL0.8 -PCPC8PC20 -WSPCWSPC8 -LCLC0.8 Ver.13.0HS ORYZA CERAMIDE Ver.13.0HS 1. 2. 20 NMR 4 ( 1) 1 Ver.13.0HS HO CH 2 OH O O OH OH OH C CH CH H 2 NH C O R C H C H (CH
untitled
NPO 2006( ) 11 14 ( ) (2006/12/3) 1 50% % - - (CO+H2) ( ) 6 44 1) --- 2) ( CO H2 ) 2 3 3 90 3 3 2 3 2004 ( ) 1 1 4 1 20% 5 ( ) ( ) 2 6 MAWERA ) MAWERA ( ) ( ) 7 6MW -- 175kW 8 ( ) 900 10 2 2 2 9 -- - 10
BAANs理論に基づく保健指導プログラム暫定版
WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal
gtf Wnt5a-Ror2 IL-8 in vitro Ozony Tron P. gingivalis SOD ELISA Location of main occluding areas and masticatory ability in patients with reduced occlusal support 12-Methacryloyloxydodecylpyridinium bromide
MP-AES ICP-QQQ Agilent 5100 ICP-OES Agilent 5100 (SVDV) ICP-OES (DSC) 1 5100 SVDV ICP-OES VistaChip II CCD Agilent 7900 ICP-MS 7700 / 10 7900 ICP-MS ICP-MS FTIR Agilent 7900 ICP-MS Agilent Cary 7000 (UMS)
42 3 u = (37) MeV/c 2 (3.4) [1] u amu m p m n [1] m H [2] m p = (4) MeV/c 2 = (13) u m n = (4) MeV/c 2 =
3 3.1 3.1.1 kg m s J = kg m 2 s 2 MeV MeV [1] 1MeV=1 6 ev = 1.62 176 462 (63) 1 13 J (3.1) [1] 1MeV/c 2 =1.782 661 731 (7) 1 3 kg (3.2) c =1 MeV (atomic mass unit) 12 C u = 1 12 M(12 C) (3.3) 41 42 3 u
1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e
No. 1 1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e I X e Cs Ba F Ra Hf Ta W Re Os I Rf Db Sg Bh
取扱説明書 [F-05E]
F-05E 12.11 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 a b 22 c d e 23 24 a o c d a b p q b o r s e f h i j k l m g f n a b c d e f g h 25 i j k l m n o p q r s a X b SD 26 27 28 X 29 a b c
4章 困難な課題への挑戦 核酸結晶学
4-2-6. I. a. DNA DNA RNA Watson & Crick 1953 b. DNA DNA DNA DNA RNA Cech et al. 1981 RNA in vitro selection DNA Breaker & Joyce 1994 2% 50% 30% International Human Genome Sequencing Consortium 2001 1 DNA
<4D F736F F D F90858C6E5F C B B B838B>
Isobutyl alcohol IUPAC 2-methylpropan-1-ol 2--1-2-Methyl-1-Propanol, Isobutanol CH 3 H 3 C OH CAS 78-83-1 C 4 H 10 O log P ow ( C) ( C) (kpa) (g/l) 74.12 74.14 1) -108 2) 108 2) 1.2 2) 87 2) 0.8 2) (74.1214)
36 th IChO : - 3 ( ) , G O O D L U C K final 1
36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic
平成26年度 化学物質分析法開発報告書
N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m
元素分析
: このマークが付してある著作物は 第三者が有する著作物ですので 同著作物の再使用 同著作物の二次的著作物の創作等については 著作権者より直接使用許諾を得る必要があります (PET) 1 18 1 18 H 2 13 14 15 16 17 He 1 2 Li Be B C N O F Ne 3 4 5 6 7 8 9 10 Na Mg 3 4 5 6 7 8 9 10 11 12 Al Si P
IS(A3) 核データ表 ( 内部転換 オージェ電子 ) No.e1 By IsoShieldJP 番号 核種核種半減期エネルギー放出割合核種番号通番数値単位 (kev) (%) 核崩壊型 娘核種 MG H β-/ce K A
IS(A3)- 284 - No.e1 核種核種半減期エネルギー放出割合核種通番数値単位 (kev) (%) 1 1 1 MG-28 20.915 H 29.08 27.0000 β-/ce K Al-28 2 1 2 MG-28 20.915 H 30.64 2.6000 β-/ce L Al-28 3 2 1 SC-44M 58.6 H 270.84 0.0828 EC/CE CA-44 4 2
50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH
3240 14 8 8 50mg 75mg 13 6 25 1-(1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH O N O C 56 H 70 N 9 NaO 23 S 1292.26 5-[(1S,2S)-2-
% %
4 8 4 5 414.5 172.1 41.5% 39.8 10% 17 186.4 70.8 4 9 10 11 3 1-1 - 2-2 - - 3 - 10% - 4 - 4060% 5560% 60% 40% 3040 1520 1015 411 7 4 11 610 7080 5060 100 3040 13-5 - 1015 4045 3.04.0 5.06.0 1.52.0 1.01.5
03J_sources.key
Radiation Detection & Measurement (1) (2) (3) (4)1 MeV ( ) 10 9 m 10 7 m 10 10 m < 10 18 m X 10 15 m 10 15 m ......... (isotope)...... (isotone)......... (isobar) 1 1 1 0 1 2 1 2 3 99.985% 0.015% ~0% E
ICP-OES ICP-MS
ICP-OES ICP-MS AGILENT CROSSLAB Agilent CrossLab Agilent CrossLab Agilent CrossLab ICP-OES ICP-MS ICP-OES ICP-MS 24 48 (www.agilent.com/chem/jp) AGILENT CROSSLAB Agilent CrossLab Agilent CrossLab Agilent
PALL NEWS vol.126 November 2017
PALL NEWS November 2017 Vol.126 PALL NEWS vol.126 November 2017 NEW =2000 9660 41.4 MPa 24 MPa NFPA T2.06.01 R2-2001 CAT C/90/* (1x10 6 0-28 MPa 1x10 6 29 120 C 60 C 450 Pa 340 Pa 1 MPa JIS B 8356-3/ISO
(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12
(1)...109 (2)...110 (1) 28...111 (2) 28...113 (1) Seg...115 (2) Seg...117 (3) Seg...119 (4) Seg...120 (1)...122 (2)...122 (3) ( )...126 (1) (PCA)...127 (2) Draize...128 (1) Ames...129 2 in vitro...132
48 13 13 13 38 21 13 3 13 3.1 l l l l l l 4.1.1 5mm 0.5mm 5mm 10 500mL 500mL 500mL 20 1 200 / 4 5 6 3000G 20 G1118 R N 2 10-8 GG Rcm Nrpm 1μm 2 3000G 1 /1 4.1.2PCB PCB 5mm 0.5mm 5mm 10 500mL 500mL 500mL
2_R_新技術説明会(佐々木)
% U: 6.58%, Np, Am:.5%, Pu:.% 5.8% Cs 6.5% Sr %.9%Mo 8.74% Tc.9% TODA C 8 H 7 C 8 H 7 N CH C CH N CH O C C 8 H 7 O N MIDOA C 8 H 7 DOODA NTA + HN(C 8 H 7 ) + H O DCC + SOCl + HN(C 8 H 7 ) + Cl TODA (TODA)
エディロールカプセルインタビューフォーム
2012 4 5 873112 2008 () 1 0.5g 0.5g 0.75g 0.75g JAN EldecalcitolJAN 2011 1 21 2011 3 11 2011 4 11 TEL0120-591-818 03-3985-5599 8:3017:00 http://www.taishotoyama.co.jp/ 20124 http://www.info.pmda.go.jp/
CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COO
CH 2 CH CH 2 CH CH 2 CH CH 2 CH 2 COONa CH 2 N CH 2 COONa O Co 2+ O CO CH 2 CH N 2 CH 2 CO 9 Change in Ionic Form of IDA resin with h ph CH 2 NH + COOH COOH COOH COO - CH 2 NH + + CH 2 NH COO - COO - COO
X線分析の進歩36 別刷
X X X-Ray Fluorescence Analysis on Environmental Standard Reference Materials with a Dry Battery X-Ray Generator Hideshi ISHII, Hiroya MIYAUCHI, Tadashi HIOKI and Jun KAWAI Copyright The Discussion Group
untitled
COLAK Mehmed 11000 305 305 180 10000 9000 8000 160 140 120 7000 100 6000 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 80 GH IGF-1 GH GH 5 4 3 2 1 0 2 3 4 5
温泉の化学 1
H O 1,003 516 149 124 2,237 1974 90 110 1km 2,400 ( 100 Mg 200 (98 ) 43,665 mg 38,695 mg 19,000 mg 2000 2000 Na-Ca-Cl 806 1970 1989 10 1991 4 ph 1 981 10,000 1993... (^^; (SO_4^{2-}) " " 1973-1987 1970
Fig. ph Si-O-Na H O Si- Na OH Si-O-Si OH Si-O Si-OH Si-O-Si Si-O Si-O Si-OH Si-OH Si-O-Si H O 6
NMR ESR NMR 5 Fig. ph Si-O-Na H O Si- Na OH Si-O-Si OH Si-O Si-OH Si-O-Si Si-O Si-O Si-OH Si-OH Si-O-Si H O 6 Fig. (a) Na O-B -Si Na O-B Si Fig. (b) Na O-CaO-SiO Na O-CaO-B -Si. Na O-. CaO-. Si -. Al O
Contents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene
Nalgene & Packaging plastic Bottles & Vials Contents 4 06 IP2 41 Thermo Scientific Nalgene 5 07 42 8 08 43 9 09 45 11 10 46 Nalgene 12 11 50 13 12 53 01 20 13 61 02 28 14 64 03 33 15 66 04 37 16 / 67 05
2016/17 P 1 P 8 P13 P18 P23 P28 7 P33 P41 15 P48 P65 GC-MS/MSLC-MS/MS 2016/17 2016 48 1.00 AH3 75.4% HI AH1pdm09 B AH3 D151GD151N HA AH1pdm09 AH3 B 5000 500 2016/17-1 - 2016 2017 78 24 well MDCKLLC-MK2HEp-2HeLa
外因性内分泌攪乱化学物質調査暫定マニュアル(水質、底質、水生生物)
N- 1) 2) 1) GC/MS HPLC GC/MS 2) 0.01~0.05µg/l 0.5~50µg/kg GC/MS SIM GC/MS SIM GC/MS SIM a) b) -d 10 -d 10 -d 12 -d 12 c) d) 600 C 4 e) 1 99.999% f) a) b) - IX-1 - c) (ODS) 200-1,000mg 5ml 5ml 5ml d) e)
RAA-05(201604)MRA対応製品ver6
M R A 対 応 製 品 ISO/IEC 17025 ISO/IEC 17025は 試験所及び校正機関が特定の試験又は 校正を実施する能力があるものとして認定を 受けようとする場合の一般要求事項を規定した国際規格 国際相互承認 MRA Mutual Recognition Arrangement 相互承認協定 とは 試験 検査を実施する試験所 検査機関を認定する国際組織として ILAC 国際試験所認定協力機構
ESL ()-methyl 3-{4-[2-hydroxy-3-(isopropylamino)pro poxy]phenyl} propanoate monohydrochloride H 3 C O O JAN( ) JAN( )esmolol hydrochloride r-inn( )esm
1 186 186 (1) - 192 (2) (ISAintrinsic sympathomimetic activity) 199 (3) ( MSAmembrane stabilizing activity) 2 (4) 21 (5) 212 (6) 216 (7) 219 (8) 224 (9) (ASL-8123) - 229 (1) d-esl l-esl - 231 2 235 235
取扱説明書 [F-12C]
F-12C 11.7 1 2 3 4 5 6 7 8 9 10 11 12 13 14 a bc b c d d a 15 a b cd e a b c d e 16 17 18 de a b 19 c d 20 a b a b c a d e k l m e b c d f g h i j p q r c d e f g h i j n o s 21 k l m n o p q r s a X
1 WSV SIR m/z Analyte RT (Min) SIR m/z Cone voltage (V) Ascorbic Acid (C).91 177 2 Thiamine (B1) 1.1 265 5 Nicotinic Acid (B3) 1.27 124 15 Pyridoxal (
ACQUITY UPLC H-Class ACQUITY QDa Mark E. Benvenuti, Dimple Shah, and Jennifer A. Burgess Waters Corporation, Milford, MA, USA MS ACQUITY QDa UPLC HPLC UV ACQUITY QDa LC EC 1925/26 CFR 21 HPLC 1 LC-MS ACQUITY
200 30 984 1 1854 1713 1000 1008 ED ADL/QOL The European Working Group on Sarcopenia in Older People EWGSOP Asian Working Group for Sarcopenia AWGS D C Zhang, 2006 C Imamura, 2008 ATP Imamura, 2009 Imamura,
2 Zn Zn + MnO 2 () 2 O 2 2 H2 O + O 2 O 2 MnO 2 2 KClO 3 2 KCl + 3 O 2 O 3 or 3 O 2 2 O 3 N 2 () NH 4 NO 2 2 O + N 2 ( ) MnO HCl Mn O + CaCl(ClO
1 [1]. Zn + 2 H + Zn 2+,. K Ca Na Mg Al Zn Fe Ni Sn Pb H Cu Hg Ag Pt Au H (H + ),,. [2] ( ) ( ) CO 2, S, SO 2, NH 3 () + () () + () FeS Fe S ( ) + ( ) ( ) + ( ) 2 NH 4 Cl + Ca(OH) 2 Ca O + 2 NH 3,.,,.,,.,.
物理化学I-第12回(13).ppt
I- 12-1 11 11.1 2Mg(s) + O 2 (g) 2MgO(s) [Mg 2+ O 2 ] Zn(s) + Cu 2+ (aq) Zn 2+ (aq) + Cu(s) - 2Mg(s) 2Mg 2+ (s) + 4e +) O 2 (g) + 4e 2O 2 (s) 2Mg(s) + O 2 (g) 2MgO(s) Zn(s) Zn 2+ (aq) + 2e +) Cu 2+ (aq)
-------------------------------------------------------------------------------------------------- 1 ----------------------------------------- 3 --------------------------------------------------------------------------------
ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1
ORYZA OIL & FAT CHEMICAL CO., LTD. ALPHA LIPOIC ACID --P () --P80 () --WSP8 () --L1 () --PC () --PC80 () --WSPC8 () --LC1 () ver. 5.1HS ver5.1 HS 1. ALPHA LIPOIC ACID 16 3 31 0331009 - () 19 5 24 0524001
untitled
20073-1- 3 4 5 9 12 14 17-2- 3,700ha 30,000t -3- 1t 70 50 40 C/N -4- 20011228 C/N 13 2001 2cm 1t 60 70 60-5- 70 1t -6- 2003131 ph EC T-C T-N C/N P2O5 K2O CaO MgO HO 2 ms % % % % % % % 8.52 0.64 74.9 44.9
125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10
. (1) 125 1 125 Renagel PB-94 P intact-pth P 1 b c a b 1 18 2 3 3 3 1 P 4 D 1 5 6 7 2 1HIV 2 3 4 5Hb 8.0g/dL ALT 48IU/L 6 7 PB-94 440mg 403mg 1-196 125 2 P 1st washout 2 PB-94 1 2 4 4 P 2.5 5.5mg/dL 1
RN201602_cs5_0122.indd
ISSN 1349-1229 No.416 February 2016 2 SPECIAL TOPIC113 SPECIAL TOPIC 113 FACE Mykinso 113 SPECIAL TOPIC IUPAC 11320151231 RI RIBFRILAC 20039Zn30 Bi83 20047113 20054201283 113 1133 Bh107 20082009 113 113
コロイド化学と界面化学
x 25 1 kg 1 kg = 1 l mmol dm -3 ----- 1000 mg CO 2 -------------------------------------250 mg Li + --------------------------------1 mg Sr 2+ -------------------- 10
BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
1/120 別表第 1(6 8 及び10 関係 ) 放射性物質の種類が明らかで かつ 一種類である場合の放射線業務従事者の呼吸する空気中の放射性物質の濃度限度等 添付 第一欄第二欄第三欄第四欄第五欄第六欄 放射性物質の種類 吸入摂取した 経口摂取した 放射線業 周辺監視 周辺監視 場合の実効線 場合
1/120 別表第 1(6 8 及び10 関係 ) 放射性物質の種類が明らかで かつ 一種類である場合の放射線業務従事者の呼吸する空気中の放射性物質の濃度限度等 添付 第一欄第二欄第三欄第四欄第五欄第六欄 放射性物質の種類 吸入摂取した 経口摂取した 放射線業 周辺監視 周辺監視 場合の実効線 場合の実効線 務従事者 区域外の 区域外の 量係数 量係数 の呼吸す 空気中の 水中の濃 る空気中 濃度限度
平成26年度 化学物質分析法開発報告書
2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)
PowerPoint プレゼンテーション
ICP-AES, AA ppb - 1% ICP-MS ppt - 100ppm SEM-EDX 0.1% - 100% B - U XRF 0.01% - 100% Na - U EMIA ppm - 100% C, S EMGA EMIA : EMGA ppm - 100% O, N, H Carbon Sulfur Nitrigen Oxygen ISO ISO/TC 17/SC ISO 9556
AS LMD Sampling Manual
AS LMD Application Solutions LaserMicrodissection System LMD SamplingManual 2005 1 AS LMD Sampling Manual -------------------------------------------------------------2 --------------------------------------
食糧 その科学と技術 No.43( )
53 inclusion body: 75 20 1 2 3 90 2000 CA 2001 CA 54 1 Refolding on Resin Dilution additive methods 2 1 2 3 4 1990 55 3 CA 4 5 6 17-1,4- CA CA 7 CA 20 DnaJ, DnaK, GroEL/ES 1 CA 2 CA 3 2 1 6M 2 56 4 1 2
エクラー軟膏0.3%、エクラークリーム0.3%、エクラーローション0.3%_IF
2005 1 872646 IF 1998 9 1g 3mg(0.3%) Deprodone Propionate 2003227 200374 1997415( ) 1998316( ) F A X 2003 7 1992 3 17 1997 10 9 1992 5 22 1997 12 19 IF 2005 4 IF 1. MR 63 2 IF 10 3 IF 2. IF IF IF 3. IF
